NO20090439L - Vaksiner og metoder for a kontrollere adipositet - Google Patents

Vaksiner og metoder for a kontrollere adipositet

Info

Publication number
NO20090439L
NO20090439L NO20090439A NO20090439A NO20090439L NO 20090439 L NO20090439 L NO 20090439L NO 20090439 A NO20090439 A NO 20090439A NO 20090439 A NO20090439 A NO 20090439A NO 20090439 L NO20090439 L NO 20090439L
Authority
NO
Norway
Prior art keywords
adiposity
vaccines
methods
control
immune conjugates
Prior art date
Application number
NO20090439A
Other languages
English (en)
Inventor
Kim D Janda
Eric P Zorrilla
Michael M Meijler
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Publication of NO20090439L publication Critical patent/NO20090439L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SAMMENDRAG Det beskrives immunkonjugater for å svekke vektøkning og behandle fedme i et individ. Immunkonjugatene omfatter særlige ghrelinpolypeptider og en egnet bærerdel.
NO20090439A 2006-08-01 2009-01-29 Vaksiner og metoder for a kontrollere adipositet NO20090439L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82107106P 2006-08-01 2006-08-01
PCT/US2007/074976 WO2008016976A2 (en) 2006-08-01 2007-08-01 Vaccines and methods for controlling adiposity

Publications (1)

Publication Number Publication Date
NO20090439L true NO20090439L (no) 2009-03-19

Family

ID=38997839

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090439A NO20090439L (no) 2006-08-01 2009-01-29 Vaksiner og metoder for a kontrollere adipositet

Country Status (15)

Country Link
US (1) US9675679B2 (no)
EP (1) EP2046376B1 (no)
JP (1) JP2009545618A (no)
KR (1) KR101510082B1 (no)
CN (1) CN101500602A (no)
AU (1) AU2007281131B2 (no)
BR (1) BRPI0715345A8 (no)
CA (1) CA2659264C (no)
CR (1) CR10644A (no)
EA (1) EA200970166A1 (no)
IL (1) IL196720A0 (no)
MA (1) MA30637B1 (no)
MX (1) MX2009001133A (no)
NO (1) NO20090439L (no)
WO (1) WO2008016976A2 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8992928B2 (en) 2006-02-11 2015-03-31 Victor Raso Isolated monoclonal antibody or antigen-binding fragment that cleaves octanoylated native ghrelin
WO2010089757A2 (en) * 2008-11-07 2010-08-12 Usv Limited An improved process for synthesis of cyclic octapeptide
AU2012214827B2 (en) * 2011-02-09 2016-06-09 The Scripps Research Institute Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
WO2013119800A1 (en) 2012-02-07 2013-08-15 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
WO2014144231A1 (en) 2013-03-15 2014-09-18 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
US10317418B2 (en) 2015-02-24 2019-06-11 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
JPWO2017170494A1 (ja) * 2016-03-29 2019-02-14 国立大学法人 東京大学 抗肥満ワクチン

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596792A (en) 1981-09-04 1986-06-24 The Regents Of The University Of California Safe vaccine for hepatitis containing polymerized serum albumin
JPS5938877A (ja) 1982-08-30 1984-03-02 Musashi Eng Kk 紙葉判別方法
US4599231A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4599230A (en) 1984-03-09 1986-07-08 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
US4608251A (en) 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues
US4601903A (en) 1985-05-01 1986-07-22 The United States Of America As Represented By The Department Of Health And Human Services Vaccine against Neisseria meningitidis Group B serotype 2 invasive disease
ES2401939T3 (es) * 1999-07-23 2013-04-25 Kenji Kangawa Nuevos péptidos
GB2357084A (en) * 1999-12-06 2001-06-13 Amersham Pharm Biotech Uk Ltd A hydrophobic carrier peptide
CA2411667A1 (en) * 2000-05-30 2001-12-06 Merck & Co. Inc. Ghrelin analogs
KR20050027168A (ko) * 2002-07-19 2005-03-17 사이토스 바이오테크놀로지 아게 그렐린-캐리어 컨쥬게이트
EP1407779A1 (en) * 2002-10-10 2004-04-14 Gastrotech A/S Use of ghrelin for treating low body weight and body fat in gastrectomized individuals
US20070134762A1 (en) * 2003-12-17 2007-06-14 Arumugham Rasappa G Immunogenic peptide carrier conjugates and methods of producing same
AU2005205181A1 (en) * 2004-01-20 2005-07-28 Cytos Biotechnology Ag Particle-induced ghrelin immune response
WO2005097173A2 (en) * 2004-04-07 2005-10-20 Gastrotech Pharma A/S Use of ghrelin for the treatment of hyperthyroidism
US20070237775A1 (en) * 2004-07-14 2007-10-11 Eli Lilly And Company Anti-Ghrelin Antibodies
CN101119749A (zh) * 2004-10-25 2008-02-06 赛托斯生物技术公司 肠抑胃肽(gip)抗原阵列及其用途
US8992928B2 (en) * 2006-02-11 2015-03-31 Victor Raso Isolated monoclonal antibody or antigen-binding fragment that cleaves octanoylated native ghrelin

Also Published As

Publication number Publication date
WO2008016976A2 (en) 2008-02-07
EP2046376A2 (en) 2009-04-15
CA2659264C (en) 2016-01-26
KR20090041416A (ko) 2009-04-28
BRPI0715345A8 (pt) 2019-01-08
CR10644A (es) 2009-04-16
KR101510082B1 (ko) 2015-04-10
JP2009545618A (ja) 2009-12-24
US9675679B2 (en) 2017-06-13
MX2009001133A (es) 2009-02-11
EP2046376A4 (en) 2010-01-27
CA2659264A1 (en) 2008-02-07
US20100021487A1 (en) 2010-01-28
MA30637B1 (fr) 2009-08-03
WO2008016976A8 (en) 2009-08-06
AU2007281131A1 (en) 2008-02-07
BRPI0715345A2 (pt) 2013-06-18
AU2007281131B2 (en) 2012-11-29
CN101500602A (zh) 2009-08-05
WO2008016976B1 (en) 2008-11-06
WO2008016976A3 (en) 2008-09-25
IL196720A0 (en) 2011-08-01
EP2046376B1 (en) 2018-08-01
EA200970166A1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
NO20090439L (no) Vaksiner og metoder for a kontrollere adipositet
NO20092052L (no) Antistoffer og immunkonjugater, og anvendelser derav
NO20085396L (no) Antistoffer og immunkonjugater, og anvendelser derav
CY1123035T1 (el) Μεθοδοι και συνθεσεις με βαση συζευγματα τοξινης της διφθεριτιδας-ιντερλευκινης-3
DK2176296T3 (da) Anti-CD79B-antistoffer og immunkonjugater og anvendelsesfremgangsmåder.
DK2444806T3 (da) Haptener, haptenkonjugater, sammensætninger deraf og fremgangsmåde til deres fremstilling og anvendelse
DE602005020837D1 (de) Il-7-varianten mit reduzierter immunogenität
NO20070699L (no) Spesielle aminoalkylglukosaminidfosfatforbindelser og deres anvendelse
PL2921500T3 (pl) Genetycznie zmodyfikowane ludzkie linie komórkowe naturalni zabójcy
DK1957539T3 (da) Humane monoklonale antistoffer til proteintyrosinkinase 7 (ptk7) og deres anvendelse
NO20092186L (no) Faktor IX del-polymer konjugater med en utlosbar binding
DK2124613T3 (da) Sammensætninger og fremgangsmåder til kontrol af kæledyrs vægt
ZA200609500B (en) Adjuvanted Shiga toxin B-subunit based vaccines
DK1960434T3 (da) Monoklonale, humane antistoffer mod Fucosyl-GM1 og fremgangsmåder til anvendelse af anti-Fucosyl-GM1
DK3903829T3 (da) Immunkonjugater med en intracellulær spaltelig binding
MY148763A (en) Anti-5t4 antibodies and uses thereof
DK2457919T3 (da) Oligosaccharider, der omfatter en aminooxygruppe, og konjugater deraf
DK2049097T3 (da) Sammensætning og fremgangsmåde til at binde acetaldehyd i maven
MX2021013657A (es) Conjugados de anticuerpo y farmaco.
EP2207156A4 (en) SIGNATURE GENERATION DEVICE, SIGNATURE VERIFICATION DEVICE, METHODS AND PROGRAMS THEREOF
NO20083609L (no) Fremgangsmater og sammensetninger for malrettet-RELT
MX2023005381A (es) Conjugados de anticuerpo y farmaco.
WO2005085420A3 (de) Leukozytenstimulations-matrix
NZ593215A (en) Prestressed slab element with stressing elements in a wave shape.
NO20076296L (no) Fremgangsmate og anordning for a oke brennenergi og anordning for a oke brennenergi produsert av naturlige brenselgasser

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application